Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
Department of Microbiology, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
Indian J Dermatol Venereol Leprol. 2017 Nov-Dec;83(6):650-655. doi: 10.4103/ijdvl.IJDVL_795_16.
Nail involvement in psoriasis is common with a lifetime incidence of 80-90%. It may reflect severity of cutaneous involvement and predict joint disease. Yet it remains, poorly studied and evaluated especially in Indian psoriatic patients.
The present study was undertaken to evaluate clinical and serological profile of nail involvement in psoriasis and to assess quality of life impairment associated with nail involvement in Indian patients.
Consecutive patients with nail psoriasis were assessed for severity of cutaneous disease (psoriasis area severity index score) and nail disease (nail psoriasis severity index score). The impairment in quality of life attributable to nail disease was scored with nail psoriasis quality of life 10 score. All patients were also assessed for joint disease and tested for inflammatory and serological markers as erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citrullinated peptide antibodies.
In our cohort of 38 patients with nail psoriasis, 9 had concomitant psoriatic arthritis. The mean psoriasis area severity index was 14.4 ± 9.6 (range = 0.4-34). The most commonly recorded psoriatic nail changes were pitting (97.4%), onycholysis (94.7%) and subungual hyperkeratosis (89.5%). The mean nail psoriasis severity index score was 83.2 ± 40.1 (range = 5-156) and mean nail psoriasis quality of life 10 was 1.1 ± 0.4. Erythrocyte sedimentation rate and C-reactive protein were raised in 22/38 (57.9%) and 15/38 (39.5%) patients, respectively; rheumatoid factor was positive in 5/38 (13.2%) and anti-cyclic citrullinated peptide antibody was raised in 4/38 (10.5%) patients.
Small sample size and lack of a control group.
In Indian patients with nail psoriasis, severity of nail involvement was found to be poorly correlated with the extent of cutaneous disease. In addition the impact of nail disease on patient's quality of life was found to be minimal. This suggests the need for a quality of life questionnaire suited to the Indian population. Serological markers were raised overall in the study patients and more so in the patients with concomitant arthritis.
指甲受累在银屑病中很常见,终生发病率为 80-90%。它可能反映皮肤受累的严重程度,并预测关节疾病。然而,它仍然研究不足,评估不足,尤其是在印度银屑病患者中。
本研究旨在评估银屑病指甲受累的临床和血清学特征,并评估印度患者指甲受累相关的生活质量受损情况。
对指甲银屑病患者进行皮肤疾病严重程度(银屑病面积严重程度指数评分)和指甲疾病(指甲银屑病严重程度指数评分)评估。指甲疾病导致的生活质量受损情况用指甲银屑病生活质量 10 分进行评分。所有患者还进行关节疾病评估,并检测炎症和血清学标志物,如红细胞沉降率、C 反应蛋白、类风湿因子和抗环瓜氨酸肽抗体。
在我们的 38 例指甲银屑病患者队列中,有 9 例合并银屑病关节炎。平均银屑病面积严重程度指数为 14.4±9.6(范围=0.4-34)。最常见的银屑病指甲改变为凹陷(97.4%)、甲剥离(94.7%)和甲下过度角化(89.5%)。平均指甲银屑病严重程度指数评分为 83.2±40.1(范围=5-156),平均指甲银屑病生活质量 10 分为 1.1±0.4。红细胞沉降率和 C 反应蛋白升高分别见于 22/38(57.9%)和 15/38(39.5%)患者;类风湿因子阳性见于 5/38(13.2%),抗环瓜氨酸肽抗体升高见于 4/38(10.5%)患者。
样本量小,缺乏对照组。
在印度指甲银屑病患者中,指甲受累的严重程度与皮肤疾病的严重程度相关性较差。此外,指甲疾病对患者生活质量的影响很小。这表明需要一种适合印度人群的生活质量问卷。研究患者的血清学标志物总体升高,伴关节炎患者更为明显。